参考文献/References:
[1].Khan A,Gurvitz M. Epidemiology of ACHD:what has changed and what is changing?[J].Prog Cardiovasc Dis,2018,61(3-4):275-281.
[2].Bergmann O,Bhardwaj RD,Bernard S,et al. Evidence for cardiomyocyte renewal in humans[J].?Science,2009,324(5923):98-102.
[3].Wang H,Yang Y,Liu J,et al. Direct cell reprogramming:approaches,mechanisms and progress[J].?Nat Rev Mol Cell Biol, 2021,22(6):410-424.
[4].Qian L,Huang Y,Spencer CI,et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes[J].?Nature,2012,485(7400):593-598.
[5].ayawardena TM,Egemnazarov B,Finch EA,et al. MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes[J].?Circ Res,2012,110(11):1465-1473.
[6].Tani H,Sadahiro T,Yamada Y,et al. Direct reprogramming improves cardiac function and reverses fibrosis in chronic myocardial infarction[J]. Circulation,2023,147(3):223-238.
[7].Lalit PA,Salick MR,Nelson DO,et al. Lineage reprogramming of fibroblasts into proliferative induced cardiac progenitor cells by defined factors[J]. Cell Stem Cell,2016,18(3):354-367.
[8].Muraoka N,Yamakawa H,Miyamoto K,et al. MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures[J].?EMBO J,2014,33(14):1565-1581.
[9].Yamakawa H,Ieda M. Cardiac regeneration by direct reprogramming in this decade and beyond[J].?Inflamm Regen,2021,41(1):20.
[10].Li CJ,Madhu V,Balian G,et al. Cross-talk between VEGF and BMP-6 pathways accelerates osteogenic differentiation of human adipose-derived stem cells[J].?J Cell Physiol,2015,230(11):2671-2682.
[11].Smart N,Riley PR. The stem cell movement[J].?Circ Res,2008,102(10):1155-1168.
[12].Bolli R,Chugh AR,D’Amario D,et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO):initial results of a randomised phase 1 trial[J].?Lancet,2011,378(9806):1847-1857.
[13].van Berlo JH,Kanisicak O,Maillet M,et al. c-kit+ cells minimally contribute cardiomyocytes to the heart[J].?Nature,2014,509(7500):337-341.
[14].Kawaguchi S,Soma Y,Nakajima K,et al. Intramyocardial transplantation of human iPS cell-derived cardiac spheroids improves cardiac function in heart failure animals[J]. JACC Basic Transl Sci,2021,6(3):239-254.
[15].Makkar RR,Smith RR,Cheng K,et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS):a prospective,randomised phase 1 trial[J].?Lancet,2012,379(9819):895-904.
[16].Makkar RR,Kereiakes DJ,Aguirre F,et al. Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR):a randomized,placebo-controlled,double-blinded trial[J].?Eur Heart J,2020,41(36):3451-3458.
[17].Vagnozzi RJ,Maillet M,Sargent MA,et al. An acute immune response underlies the benefit of cardiac stem?cell therapy[J].?Nature,2020,577(7790):405-409.
[18].Mummery CL,Zhang J,Ng ES,et al. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes:a methods overview[J].?Circ Res,2012,111(3):344-358.
[19].Liu YW,Chen B,Yang X,et al. Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates[J].?Nat Biotechnol,2018,36(7):597-605.
[20].Romagnuolo R,Masoudpour H,Porta-Sánchez A,et al. Human embryonic stem cell-derived cardiomyocytes regenerate the infarcted pig heart but induce ventricular tachyarrhythmias[J].?Stem Cell Reports,2019,12(5):967-981.
[21].Takahashi K,Tanabe K,Ohnuki M,et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors[J].?Cell,2007,131(5):861-872.
[22].Soma Y,Tani H,Morita-Umei Y,et al. Pluripotent stem cell-based cardiac regenerative therapy for heart failure[J]. J Mol Cell Cardiol,2024,187:90-100.
[23].Romagnuolo R,Masoudpour H,Porta-Sánchez A,et al. Human embryonic stem cell-derived cardiomyocytes regenerate the infarcted pig heart but induce ventricular tachyarrhythmias[J].?Stem Cell Reports,2019,12(5):967-981.
[24].Querdel E,Reinsch M,Castro L,et al. Human Engineered Heart Tissue Patches Remuscularize the Injured Heart in a Dose-Dependent Manner[J]. Circulation,2021,143(20):1991-2006.
[25].Lou X,Tang Y,Ye L,et al. Cardiac muscle patches containing four types of cardiac cells derived from human pluripotent stem cells improve recovery from cardiac injury in mice[J]. Cardiovasc Res,2023,119(4):1062-1076.
[26].Miyagawa S,Kainuma S,Kawamura T,et al.Transplantation of IPSC-derived cardiomyocyte patches for ischemic cardiomyopathy[J]. Front Cardiovasc Med,2022,9:950829.
[27].Mohamed TMA,Ang YS,Radzinsky E,et al. Regulation of cell cycle to stimulate adult cardiomyocyte proliferation and cardiac regeneration[J].?Cell,2018,173(1):104-116.e12.
[28].Abouleisa RRE,Salama ABM,Ou Q,et al. Transient cell cycle induction in cardiomyocytes to treat subacute ischemic heart failure[J].?Circulation,2022,145(17):1339-1355.
[29].van Amerongen MJ,Diehl F,Novoyatleva T,et al. E2F4 is required for cardiomyocyte proliferation[J].?Cardiovasc Res,2010,86(1):92-102.
[30].Mahmoud AI,Kocabas F,Muralidhar SA,et al. Meis1 regulates postnatal cardiomyocyte cell cycle arrest[J].Nature,2013,497(7448):249-253.
[31].Li X,Wu F,Günther S,et al. Inhibition of fatty acid oxidation enables heart regeneration in adult mice[J].?Nature,2023,622(7983):619-626.
[32].Feng J,Li Y,Li Y,et al. Versican promotes cardiomyocyte proliferation and cardiac repair[J]. Circulation,2024,149(13):1004-1015.
[33].Wang YT,Lim Y,McCall MN,et al. Cardioprotection by the mitochondrial unfolded protein response requires ATF5[J].?Am J Physiol Heart Circ Physiol,2019,317(2):H472-H478.
[34].Gao F,Liang T,Lu YW,et al. Reduced mitochondrial protein translation promotes cardiomyocyte proliferation and heart regeneration[J].?Circulation,2023,148(23):1887-1906.